Summit Therapeutics (SMMT) was upgraded by Truist Financial Corporation to "strong-buy".
Prediction: 2 Stocks That Will Be Worth More Than Summit Therapeutics 1 Year From Now [Yahoo! Finance]
Summit Therapeutics (SMMT) was downgraded by Jefferies Financial Group Inc. from "buy" to "hold". They now have a $15.00 price target on the stock.
Summit Therapeutics Inc. (SMMT) Presents at The Citizens Life Sciences Conference 2026 Transcript [Seeking Alpha]
Summit Therapeutics (SMMT) was upgraded by Zacks Research from "strong sell" to "hold".